The isolation and characterization of human monoclonal antibodies (humAbs) against the hepatitis C Virus (HCV) glycoproteins E1 and E2 are described. B-cells from blood donors with anti-HCV were transformed with Epstein-Barr virus. The supernatants of the resulting lymphoblastoid clones were screene
5180813 Early envelope glycoprotein of human cytomegalovirus (HMCV) and monoclonal antibodies to the glycoproteins
- Book ID
- 103118797
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 95 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0020-711X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A human monoclonal antibody to cytomegalovirus (CMV) was produced by transforming peripheral blood mononuclear cells of a patient with recent CMV infection. It is directed against a late antigen located in the nucleus of CMV infected fibroblasts at 24-72 hours postinfection and immuneprecipitates 65
## Abstract The monoclonal antibody (F10β89β4) described in this study recognizes an antigen which by quantitative absorption analysis is absent from human brain, kidney, liver, heart, erythrocytes, platelets and normal serum, but is present on spleen, lymph node, chronic lymphatic leukemia cells,
Active and/or passive immunoprophylaxis against hepatitis C virus (HCV) remain unachieved goals. Monoclonal antibodies might provide one approach to protection. We derived human monoclonal antibodies from the bone marrow of a patient with a well-controlled HCV infection of 22 years duration. Five di